Welcome to our dedicated page for Esquire Financial Holdings SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Esquire Financial Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Esquire Financial Holdings's regulatory disclosures and financial reporting.
Esquire Financial Holdings, Inc. director Anthony Coelho exercised stock options for 20,000 shares of common stock on August 7, 2026 at an exercise price of $12.50 per share. In connection with this exercise, 1,902 shares of common stock were delivered or withheld for payment of exercise price or tax liability at $131.38 per share. The stock options exercised were fully vested. Following these transactions, Coelho reported indirect holdings of 12,910 shares of common stock held by a trust and 36,000 shares held by an IRA, with portions of his reported common stock position consisting of restricted stock that vests in full or in installments between December 2024 and December 2027.
Esquire Financial Holdings reported solid growth for the six months ended June 30, 2026. Total assets rose to $2.51 billion from $2.37 billion, driven mainly by loans held for investment increasing to $1.90 billion from $1.76 billion. Total deposits grew to $2.18 billion from $2.06 billion, with most funding in savings, NOW and money market accounts.
For the quarter, net income was $12.98 million versus $11.89 million a year earlier; six‑month net income was $25.19 million versus $23.30 million. Diluted EPS was $1.49 for the quarter and $2.89 year‑to‑date, compared with $1.38 and $2.70, respectively. Net interest income for the first half increased to $69.75 million from $56.86 million, while provision for credit losses was $5.60 million, up from $5.03 million, and the allowance for credit losses stood at $24.72 million.
Subsequent to quarter‑end, Esquire completed a stock‑for‑stock merger with Signature Bancorporation. Signature shareholders received 2.671 Esquire shares per Signature share, for total consideration of about $466 million. Based on June 30, 2026 data, the combined company has roughly $4.8 billion in assets, $3.3 billion in loans, and $4.0 billion in deposits. Merger‑related expenses were $2.3 million year‑to‑date and are described as non‑recurring.
Mawer Investment Management Ltd. filed Amendment No. 2 to a Schedule 13G reporting its beneficial ownership in Esquire Financial Holdings, Inc. common stock. Mawer reports beneficial ownership of 583,871 shares of common stock, representing 6.76% of the outstanding class.
Mawer has sole voting power and sole dispositive power over all 583,871 shares, with no shared voting or dispositive power. The ownership percentage is based on 8,639,431 shares of Esquire common stock outstanding as of April 29, 2026, as reported by the issuer. The filing is signed by portfolio manager John Wilson on August 5, 2026.
Esquire Financial Holdings director Leonard Caronia exercised 2,232 stock options on August 4, 2026 at an exercise price of $19.57 per share, converting them into 2,232 shares of common stock held indirectly through a corporation. To cover the option exercise price or related tax obligations, 335 indirectly held shares were withheld at $130.31 per share. Caronia continues to hold multiple option grants on additional shares, many fully vested and others vesting annually beginning May 26, 2027, with exercise prices ranging from $22.41 to $111.14 and expirations from 2027 through 2036.
Esquire Financial Holdings, Inc. director Leonard Caronia reported merger-related equity acquisitions on August 1, 2026. In connection with the March 11, 2026 merger with Signature Bancorporation, 98864.0000 shares of common stock are indirectly held "By corporation," reflecting the 2.671-for-1 share conversion.
Multiple Signature stock options converted into options on Esquire common stock at adjusted exercise prices (for example, 2232.0000 shares at $19.5700 per share). Most converted options are fully vested, while the 950.0000-share series with a $111.1400 exercise price vests in five equal annual installments beginning May 26, 2027.
Esquire Financial Holdings, Inc. reporting person Michael G. O'Rourke, President of the Chicago Bank Division, reported multiple acquisitions on 2026-08-01 tied to the merger with Signature Bancorporation. Signature common stock and stock options converted into Esquire equity at a 2.671-for-1 ratio, resulting in 66726 common shares held directly and 18630 held indirectly via an IRA, plus several Esquire stock option awards with exercise prices from $19.5700 to $111.1400 per share. Most options are fully vested; one grant vests in five equal annual installments commencing on May 26, 2027.
Esquire Financial Holdings, Inc. director Caronia Leonard reports a holding in Common Stock with direct ownership of 0.0000 shares following the reported entry dated August 1, 2026. The report records one holding entry and shows no buy or sell transactions in company shares.
Esquire Financial Holdings, Inc. filed an initial statement of beneficial ownership for Michael G. O'Rourke, who serves as a director and as President of Chicago Bank Div. The filing reports Common Stock with 0.0000 shares held directly following the reported position entry.
Esquire Financial Holdings, Inc. director Robert Mitzman reported a sale of 3,000 shares of common stock on July 30, 2026 in a transaction coded as a sale in an open market or private transaction at $129.5973 per share. Following this sale, he directly holds 139,679 shares of common stock, which include multiple grants of restricted stock that vest between December 2024 and December 2027. He also holds 2,500 shares indirectly through an insurance trust I and 2,500 shares indirectly through an insurance trust II.
Esquire Financial Holdings, Inc. completed its previously announced merger with Signature Bancorporation, Inc. on August 1, 2026. A merger subsidiary first combined with Signature, which then merged into Esquire, followed by the merger of Signature Bank into Esquire Bank, National Association, with Esquire Bank as the surviving bank.
Each share of Signature common stock was converted into the right to receive 2.671 shares of Esquire common stock, with cash paid in lieu of fractional shares. Outstanding Signature stock options (other than those granted after March 11, 2026) fully vested, were assumed by Esquire, and adjusted by the Exchange Ratio for both shares and exercise price while retaining their prior terms.
Esquire’s board was increased to ten directors, adding former Signature leaders Michael G. O’Rourke and Leonard S. Caronia, who are expected to serve through the 2027 annual meeting, subject to stockholder election. O’Rourke became President of Signature, a division of Esquire Bank, under an employment agreement, and he and certain former Signature executives are subject to a lock-up restricting sales of Esquire shares received in the merger. Esquire plans to file acquired-business financial statements and pro forma financial information by amendment within 71 days of the required filing date.